You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Claims for Patent: 11,679,116


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,679,116
Title:Topical compositions and methods for treating psoriasis
Abstract:Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
Inventor(s):Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
Assignee: Bausch Health Ireland Ltd
Application Number:US17/366,871
Patent Claims: 1. A pharmaceutical composition consisting essentially of: tazarotene, 0.045% w/w, diethyl sebacate, 2.97% w/w, light mineral oil, 8.03% w/w, sorbitan monooleate, 0.1% w/w, sorbitol solution (70%), 10.7% w/w, methyl paraben, 0.17% w/w, propyl paraben, 0.03% w/w, edetate disodium dihydrate, 0.05% w/w, carbomer copolymer type B, 0.4% w/w, carbomer homopolymer type A, 0.6% w/w, sodium hydroxide, q.s. to pH of 5.5±0.5, and purified water, q.s. to 100% w/w; wherein the composition is a lotion.

2. A method of treating psoriasis, the method comprising topically applying a pharmaceutical composition of claim 1 to an affected area of a body of a subject suffering from psoriasis; wherein said applying is carried out one or more times per day for a period of time sufficient to treat such psoriasis.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.